Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

MEK inhibitor and Novartis

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between MEK inhibitor and Novartis

MEK inhibitor vs. Novartis

A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2. Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.

Similarities between MEK inhibitor and Novartis

MEK inhibitor and Novartis have 3 things in common (in Unionpedia): Binimetinib, BRAF (gene), MEK inhibitor.

Binimetinib

Binimetinib (MEK162, ARRY-162) is a MEK inhibitor being developed by Array Biopharma to treat various cancers.

Binimetinib and MEK inhibitor · Binimetinib and Novartis · See more »

BRAF (gene)

BRAF is a human gene that encodes a protein called B-Raf.

BRAF (gene) and MEK inhibitor · BRAF (gene) and Novartis · See more »

MEK inhibitor

A MEK inhibitor is a chemical or drug that inhibits the mitogen-activated protein kinase kinase enzymes MEK1 and/or MEK2.

MEK inhibitor and MEK inhibitor · MEK inhibitor and Novartis · See more »

The list above answers the following questions

MEK inhibitor and Novartis Comparison

MEK inhibitor has 20 relations, while Novartis has 316. As they have in common 3, the Jaccard index is 0.89% = 3 / (20 + 316).

References

This article shows the relationship between MEK inhibitor and Novartis. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »